Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Melanoma Stage II”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00289640
What this trial is testing

Study of Ipilimumab (MDX-010) Monotherapy in Patients With Previously Treated Unresectable Stage III or IV Melanoma

Who this might be right for
Melanoma
Bristol-Myers Squibb 210
Testing effectiveness (Phase 2)Looking for participantsNCT04331093
What this trial is testing

Neoadjuvant SHR-1210 Plus Apatinib for Resectable Stage III-IV Acral Melanoma

Who this might be right for
Acral Melanoma
Di Wu 40
Testing effectiveness (Phase 2)Study completedNCT00936221
What this trial is testing

Comparison of AZD6244 in Combination With Dacarbazine Versus (vs) Dacarbazine Alone in BRAF Mutation Positive Melanoma Patients

Who this might be right for
Melanoma
AstraZeneca 385
Testing effectiveness (Phase 2)WithdrawnNCT04648826
What this trial is testing

Aerosolized Azacytidine as Epigenetic Priming for Bintrafusp Alfa-Mediated Immune Checkpoint Blockade in Patients With Unresectable Pulmonary Metastases From Sarcomas, Germ Cell Tumors, or Epithelial Malignancies

Who this might be right for
SarcomasMelanomasGerm Cell Tumors+2 more
National Cancer Institute (NCI)
Early research (Phase 1)Ended earlyNCT01769222
What this trial is testing

Ipilimumab and Local Radiation for Selected Solid Tumors

Who this might be right for
Adult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+31 more
Stanford University 3
Testing effectiveness (Phase 2)Study completedNCT01355120
What this trial is testing

THE IPI - Trial in Advanced Melanoma: Melanoma Patients With Advanced Disease

Who this might be right for
Ocular Melanoma
Prof. Dr. med. Dirk Schadendorf 171
Testing effectiveness (Phase 2)Study completedNCT00866840
What this trial is testing

Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery

Who this might be right for
Melanoma (Skin)
Rutgers, The State University of New Jersey 13
Testing effectiveness (Phase 2)Ended earlyNCT00550654
What this trial is testing

Conformal Radiation Therapy in Treating Patients With Metastatic Cancer Outside the Brain

Who this might be right for
Kidney CancerMelanoma (Skin)Metastatic Cancer+3 more
National Institutes of Health Clinical Center (CC) 1
Testing effectiveness (Phase 2)Study completedNCT00071981
What this trial is testing

Vaccine Therapy Using Melanoma Peptides for Cytotoxic T Cells and Helper T Cells in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
Eastern Cooperative Oncology Group 175
Early research (Phase 1)Active Not RecruitingNCT04875728
What this trial is testing

The Impact of an Antibiotic (Cefazolin) Before Surgery on the Microbiome in Patients With Stage I-II Melanoma

Who this might be right for
Clinical Stage I Cutaneous Melanoma AJCC v8Clinical Stage IA Cutaneous Melanoma AJCC v8Clinical Stage IB Cutaneous Melanoma AJCC v8+11 more
M.D. Anderson Cancer Center 20
Testing effectiveness (Phase 2)Ended earlyNCT00610311
What this trial is testing

Anti-gp100 Cells Plus ALVAC gp100 Vaccine to Treat Advanced Melanoma

Who this might be right for
Metastatic MelanomaSkin Cancer
National Cancer Institute (NCI) 3
Testing effectiveness (Phase 2)Study completedNCT02807844
What this trial is testing

Phase Ib/II Study of MCS110 in Combination With PDR001 in Patients With Advanced Malignancies

Who this might be right for
Triple Negative Breast CancerPancreatic CarcinomaMelanoma+1 more
Novartis Pharmaceuticals 141
Testing effectiveness (Phase 2)Ended earlyNCT02740920
What this trial is testing

Response to Pembrolizumab in Metastatic Melanoma: Computed Tomography Texture Analysis as a Predictive Biomarker

Who this might be right for
Metastatic Melanoma
Canadian Cancer Trials Group 9
Testing effectiveness (Phase 2)Study completedNCT00255762
What this trial is testing

Carboplatin, Paclitaxel, and Bevacizumab in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery

Who this might be right for
Recurrent MelanomaStage IV Melanoma
National Cancer Institute (NCI) 47
Testing effectiveness (Phase 2)UnknownNCT05823246
What this trial is testing

Safety and Efficacy Study of QLF31907 in Advanced Melanoma and Urothelial Carcinoma

Who this might be right for
MelanomaUrothelial Carcinoma
Qilu Pharmaceutical Co., Ltd. 66
Testing effectiveness (Phase 2)Study completedNCT00027586
What this trial is testing

Imatinib Mesylate in Treating Patients With Metastatic Melanoma

Who this might be right for
MelanomaSkin Neoplasms
M.D. Anderson Cancer Center 22
Testing effectiveness (Phase 2)UnknownNCT03138642
What this trial is testing

Mucosal Melanoma of Head and Neck in Intensity-modulated Radiotherapy Era

Who this might be right for
Mucosal Melanoma
Sun Yat-sen University 30
Testing effectiveness (Phase 2)Study completedNCT01014351
What this trial is testing

Study of Everolimus With Paclitaxel and Carboplatin in Patients With Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
SCRI Development Innovations, LLC 70
Testing effectiveness (Phase 2)Study completedNCT00096083
What this trial is testing

Hepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver Cancer

Who this might be right for
Cancer
Delcath Systems Inc. 56
Testing effectiveness (Phase 2)Study completedNCT00841204
What this trial is testing

Sulindac in Preventing Melanoma in Healthy Participants Who Are at Increased Risk of Melanoma

Who this might be right for
Precancerous Condition
National Cancer Institute (NCI) 50
Next Page